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Abstract
Background: Choriocarcinoma syndrome is known as a lethal complication from tumoral hemorrhage, which
frequently occurs at the site of tumor metastasis.
Case presentation: A 59-year-old man with 60-pack-year smoking history was referred to our hospital because of
hemoptysis. Chest computed tomography (CT) showed a 28 × 18 mm spiculated nodule with a cavity infiltrating
the left upper lobe. A transbronchial lung biopsy was performed, and histopathological examinations revealed
adenocarcinoma. No distant or regional metastasis was observed, and therefore, the patient underwent a left
upper lobectomy with lymphadenectomy. Histological examinations showed that the tumor consisted of
poorly differentiated adenocarcinoma cells and a choriocarcinomatous component; no multiple pulmonary
metastases and mediastinal lymph node metastasis were observed. Immunohistochemical analysis showed a
positive immunoreaction for human chorionic gonadotropin in the syncytiotrophoblastic cells of the
choriocarcinoma. One month after the operation, the patient developed massive hemoptysis. CT showed
diffuse alveolar infiltration in both the lungs. A bronchoscopic examination showed bleeding from the right
upper bronchus. Aspiration cytology showed carcinoma. Despite blood transfusion and management in the
intensive care unit, the patient died one and a half month after diagnosis.
Conclusions: We herein report a case of a man who developed choriocarcinoma syndrome 1 month after
resection for combined choriocarcinoma and adenocarcinoma of the lung. Choriocarcinoma syndrome is a
rare and life-threatening complication which may occur in patients with primary pulmonary choriocarcinoma.
However, we need to consider the risk of this syndrome while dealing with patients who have massive
hemoptysis.
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Background
Choriocarcinoma originates from anaplastic tropho-
blastic tissue and principally occurs in the female genital
tract after a gestational event. Extragonadal choriocar-
cinoma is a rare entity; especially, primary pulmonary
choriocarcinoma is an extremely rare entity. The lung is
the most frequent site of metastasis from choriocarcin-
oma, and a lethal hemorrhagic comolication at the sites
of metastasis is well-recognized. This is named the
choriocarcinoma syndrome, containing high-volume
choriocarcinomatous elements with siginificant elevation
of serum levels of beta-human chorionic gonadotropin
(hCG) [1].
Case presentation
A 59-year-old man with a 60-pack-year smoking history
was referred to our hospital due to hemoptysis. The pa-
tient had transurethral resection of the bladder tumor
for bladder cancer. There were no abnormalities on
physical examination, and laboratory data were within
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normal limits. His preoperative serum and urinary hCG
levels were not examined. Chest computed tomography
(CT) revealed a 28 × 18 mm speculated cavitary nodule
accompanied by parenchymal infiltration (Fig. 1). Posi-
tron emission tomography (PET)/CT showed a fluodeox-
yglucose uptake in the nodule. Transbronchial lung
biopsy revealed adenocarcinoma of the lung. In the ab-
sence of distant and regional metastasis, the patient was
diagnosed as having stage IA [cT1bN0M0] lung adeno-
carcinoma and underwent a left upper lobectomy with
lymphadenectomy. Histologic findings showed that
the tumor was consisted of the choriocarcinomatous
component (cytotrophoblastic and syncytiotriphoblas-
tic cells) and poorly diffenrentiated adenocarcinoma
(Fig. 2a). There were no multiple pulmonary metasta-
sis and mediastinal lymph node metastasis. Immuno-
histochemistry showed a positive immunoreaction for
hCG in the syncytiotrophoblastic cells of the chorio-
carcinoma (Fig. 2b).
The patient’s postoperative course was uneventful.
One month after the operation, the patient developed
massive hemoptysis. CT revealed diffuse alveolar infil-
trates in the both lungs (Fig. 3a). Bronchoscopic examin-
ation revealed massive bleeding from the right upper
bronchus (Fig. 3b). Aspiration cytology from the right
upper bronchus showed a choriocarcinoma component.
Despite blood transfusion and management in the inten-
sive care unit, the patient died.
Discussion
Choriocarcinoma is a germ cell tumor containing syn-
cytiotrophoblastic cells and secreting hCG and most
commonly occurs in the female genital tract after a
gestational event such as hydatidiform mole, spontaneous
abortion, ectopic pregnancy, or term pregnancy [2].
Primary pulmonary choriocarcinoma is an extremely
rare entity and the pathogenesis of primary pulmon-
ary choriocarcinoma has not been established yet. In
our case, the tumor was consisted of a choriocarcinoma-
tous component (cytotrophoblastic and syncytiotripho-
blastic cells) and poorly diffenrentiated adenocarcinoma.
To our knowledge, only one case of combined choriocar-
cinoma and adenocarcinoma of the lung has been re-
ported by Chen et al. so far [3]. Chen et al. reported that
there is the possibility that choriocarcinoma and
adenocarcinoma arouse simultaneously or formed a
collision tumor; however, it is considered that the
choriocarcinoma might occur directly in the lung
through trophoblastic differentiation of some cells in
the former adenocarcinoma.
No established therapeutic guidelines are available for
this clinical entity due to its rarity. In a small pulmonary
choriocarcinoma, the first choice in the treatment may
be surgical resection [4]. However, the natural course of
choriocarcinoma is rapidly fatal in the great majority of
cases, especially some patients presenting with chorio-
carcinoma syndrome which is characterized by life
threatening bleeding at the sites of metastasis from
choriocarcinoma may be threatened immediately by the
complications of pulmonary hemorrhage. Hemoptysis,
elevation of serum levels of hCG and the
roentgenographic infiltrates with typical metastatic
sharply defined nodules are characteristic with the
choriocarcinoma syndrome [1]. In our case, unfortu-
nately elevation of serum levels of hCG could not be
confirmed because the patient suffered from massive
hemoptysis and died before the pathological diagnosis of
combined choriocarinoma and adenocarcinoma of the
Fig. 1 Chest computed tomography (CT) revealed a 28 × 18 mm spiculated cavitary nodule accompanied by parenchymal infiltration in the left
upper lobe
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lung was made. Though chest CT revealed no pulmon-
ary nodules suggestive of metastasis, we could make a
definite diagnosis of choriocarcinoma syndrome from
aspiration cytology. There is a report that combined mo-
dality therapy consisting of chemotherapy including
bleomycin, etoposide, and cisplatin along with surgery
and irradiation may result in a complete response [5].
Early recognition of choriocarcinoma syndrome and the
urgent multimodality treatment consisted of surgery and
chemotherapy might be beneficial.
Conclusions
Choriocarcinoma syndrome is a rare and life-threatening
complication which may occur in patients with primary
pulmonary choriocarcinoma. However, we need to con-
sider the risk of this syndrome while dealing with pa-
tients who have massive hemoptysis.
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Fig. 3 a Chest computed tomography (CT) revealed diffuse alveolar
infiltrates in the both lungs. b Bronchoscopic examination revealed




Fig. 2 a Histologic findings showing that the tumor was consisted
of the poorly diffenrentiated adenocarcinoma (arrow) and a
choriocarcinomatous component comprised of cytotrophoblastic
(arrowhead) and syncytiotriphoblastic cells (*) (hematoxylin and
eosin stain; original magnification, ×200). b Immunohistochemistry
showing a positive immunoreaction for beta-human chorionic
gonadotropin (original magnification, ×400)
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